Dube Michael P 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Dube Michael P（CIK 2019493）在 1 家公司共报告 6 笔 SEC Form 4 内部人交易（最近一笔 2026-10-06）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-10-06 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | 卖出 | 1,864 | $23,170 |
| 2026-07-06 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | 卖出 | 2,641 | $44,316 |
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | 买入 | 17,250 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | 卖出 | 2,989 | $27,529 |
| 2025-10-03 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | 卖出 | 1,871 | $32,518 |
| 2025-07-03 | Intellia Therapeutics, Inc. (NTLA) | VP, Chief Accounting Officer | 卖出 | 2,503 | $24,905 |
来源：SEC Form 4 申报文件 · 截至 2026-10-06